VEGF overexpression predicts poor survival in hepatocellular carcinoma

Sae Byeol Choi, Hyung Joon Han, Wan Bae Kim, Tae Jin Song, Sang Yong Choi

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

The aim of this study was to investigate the clinicopathological and immunohistochemical (including VEGF, Akt, HSP70, and HSP20 expression) factors that affect the overall and disease-free survival of HCC patients following surgical resection. 234 patients with HCC following surgical resection were enrolled. Clinicopathological and survival data were analyzed, and immunohistochemical staining was performed on tissue microarray sections using the anti-VEGF, anti-Akt, anti-HSP70, and anti-HSP27 antibodies. The 3-A nd 5-year overall survival rates were 86.5 and 81.54%, respectively. Multivariate analysis revealed that VEGF expression (P = 0.017, HR = 2.573) and T stage (P < 0.001, HR = 4.953) were independent prognostic factors for overall survival. Immunohistochemical staining showed that the expression of Akt, HSP70, and HSP27 did not affect the overall survival rate. The 3-A nd 5-year disease-free survival rates were 58.2 and 49.4%, respectively. Compared to the VEGF(-)/(+) group, the VEGF(++)/(+++) group demonstrated significantly higher proportion of patients with AFP levels > 400 ng/mL, capsule invasion, and microvascular invasion. VEGF overexpression was associated with capsule invasion, microvascular invasion, and a poor overall survival rate.

Original languageEnglish
Pages (from-to)430-439
Number of pages10
JournalOpen Medicine (Poland)
Volume12
Issue number1
DOIs
Publication statusPublished - 2017 Jan 1

Keywords

  • Hepatocellular carcinoma
  • VEGF
  • hepatic resection
  • prognostic marker

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'VEGF overexpression predicts poor survival in hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this